So, Brigatinib is a kind of treatment that stops the action of ALK in patients who’ve got advanced non-small cell lung cancer (NSCLC), specifically if they have the ALK protein that’s been confirmed by an FDA test. So the suggested way to take brigatinib is starting with 90 mg every day for the first week, and then switch to 180 mg each day after that. You can get this med in three doses: 30 mg, 90 mg, and 180 mg in these easy-to-swallow, coated pills, usually coming in a pack with 30 tabs.
How it works is by stopping the signals that the ALK stuff sends, which is really important in causing ALK-positive lung cancer to grow. This drug can have pretty bad side effects, like trouble with your lungs or liver issues, so if you’ve had a serious reaction to brigatinib before, it’s best to steer clear of it.
